Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
European Medicines Agency to review Diane -35 and its generics
Notice type:
Advisory
Date:
31/01/2013
Product name or type:
Diane 35* (ethinylestradiol and cyproterone acetate) *This medicine is marketed under the brand name Dianette in Ireland
Problem Or Issue:
The European Medicines Agency (EMA) has indicated that the French medicines regulatory authority (ANSM) will request an EU wide review of Diane 35 and its generics. This review will assess the benefits and risks of these medicines and will consider any impact on their marketing authorisations. The EMA has indicated that this review will commence next week, following formal notification. Pending the outcome of the review, women who are currently taking Dianette or one of its generics are advised not to stop the medicine. If a woman has concerns, she can discuss this with her doctor.
Background Information Or Related Documents:
See the link to the EMA press release below:
EMA update on Diane 35 and generics used in the treatment of acne
European Medicines Agency to review Diane -35 and its generics Document
« Back
Date Printed: 29/03/2024